Anti-cure impact of Errant EU stem cell patent decision

There has been concern for months about the direction that the European Union was heading in regards to intellectual property (IP) rights and stem cell patent approaches. Now, a definitive decision banning embryonic stem cell (ESC)-based patents by the EU Court has dealt a severe blow to stem cell science in Europe. The European Court …

Anti-cure impact of Errant EU stem cell patent decision Read More »